pre-miRNA Information
pre-miRNA hsa-mir-4640   
Genomic Coordinates chr6: 30890883 - 30890972
Description Homo sapiens miR-4640 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-4640-5p
Sequence 9| UGGGCCAGGGAGCAGCUGGUGGG |31
Evidence Experimental
Experiments Illumina
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1392105945 7 dbSNP
rs939712790 9 dbSNP
rs762825841 15 dbSNP
rs71552023 20 dbSNP
rs1305909531 21 dbSNP
rs750017220 21 dbSNP
rs1375436057 23 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
B32FZJ miR-4640 Safety Biomarker (SAF) Clinical/Experimental Data Expression lower Urine Quantitative polymerase chain reaction
Gene Information
Gene Symbol PPIC   
Synonyms CYPC
Description peptidylprolyl isomerase C
Transcript NM_000943   
Expression
Putative miRNA Targets on PPIC
3'UTR of PPIC
(miRNA target sites are highlighted)
>PPIC|NM_000943|3'UTR
   1 CACAACTGGCAGAAAACAAGGATATGCTTTGGCAGGGGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTTGTGTTGTCTTTC
  81 AATTATTTGCTTTTTTTTTTTTACTTTCTTTTTGTATTCTATCCCAGATCACAGGAAAGTTATAAAAATCAAACCGTCAC
 161 CCTTTAGTTTGCTTGAACTTTAGTAAACCACCTGCTTAGGGACTTTGAACTTAAATATATCCCCTTCCTCAAGTGGTGCT
 241 ATTTTAAAACTAAAAAAAACTTTGAATTGGCTATTTTTTTAATGCAATATTTTTTTTCTGAATTCATTATGATCCCCATA
 321 TTGGGTAATGCTGAACATTTATCTGAAACAGATGAGGATATTATTATTTTGTATCCAAACAGAAATTCAGATAAAGGGAA
 401 ATTTGACTAGTGTAATCTGAGATATGTCATAGGGATTTCTTTCTGACAAAAGGGTGCTTTGCTGTTCTTTATATTAAATA
 481 CTTTTAGATCAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' ggguggucgacgaggGACCGggu 5'
                         |||||   
Target 5' ----------cacaaCTGGCaga 3'
1 - 13 100.00 -7.62
2
miRNA  3' ggguggUCGACGAGG-GACCGGGu 5'
                :| ||||:: ||| :|: 
Target 5' acaaaaGGGTGCTTTGCTGTTCTt 3'
446 - 469 93.00 -13.10
3
miRNA  3' ggguggUCGACGAGGGACCGGgu 5'
                | || :   :||||:  
Target 5' aaaaaaAACTTTGAATTGGCTat 3'
252 - 274 89.00 -7.30
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN5068179 2 COSMIC
COSN30483451 21 COSMIC
COSN6510237 41 COSMIC
COSN20050036 66 COSMIC
COSN20050034 67 COSMIC
COSN30470072 80 COSMIC
COSN1306243 91 COSMIC
COSN24787946 108 COSMIC
COSN15665927 109 COSMIC
COSN30162499 119 COSMIC
COSN22088707 155 COSMIC
COSN26574747 156 COSMIC
COSN31548185 265 COSMIC
COSN31563790 273 COSMIC
COSN28767871 380 COSMIC
COSN16730628 428 COSMIC
COSN14791497 567 COSMIC
COSN29323315 603 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1407480023 6 dbSNP
rs1446109445 7 dbSNP
rs367741833 13 dbSNP
rs754818746 19 dbSNP
rs370559562 21 dbSNP
rs766018743 22 dbSNP
rs760961856 24 dbSNP
rs966611319 32 dbSNP
rs1022532778 34 dbSNP
rs750629331 36 dbSNP
rs146229593 37 dbSNP
rs776662400 37 dbSNP
rs397999141 38 dbSNP
rs889673529 38 dbSNP
rs534440216 39 dbSNP
rs750956100 39 dbSNP
rs1276792180 41 dbSNP
rs1402259967 44 dbSNP
rs566741336 44 dbSNP
rs757629304 44 dbSNP
rs1341630855 46 dbSNP
rs1476610386 46 dbSNP
rs371305785 48 dbSNP
rs1389183109 64 dbSNP
rs546924735 64 dbSNP
rs10552214 67 dbSNP
rs1165001978 68 dbSNP
rs1366095543 68 dbSNP
rs1404740701 68 dbSNP
rs1427190555 68 dbSNP
rs1431234627 68 dbSNP
rs1491249003 68 dbSNP
rs70988555 68 dbSNP
rs776432929 68 dbSNP
rs879117036 68 dbSNP
rs759094553 69 dbSNP
rs1328194378 71 dbSNP
rs1401011719 72 dbSNP
rs374923857 73 dbSNP
rs1388165287 78 dbSNP
rs1433233167 86 dbSNP
rs1217395423 103 dbSNP
rs528773387 103 dbSNP
rs879309374 103 dbSNP
rs1293309453 104 dbSNP
rs1052129559 108 dbSNP
rs375067091 112 dbSNP
rs1375782890 113 dbSNP
rs1313748779 127 dbSNP
rs984369909 133 dbSNP
rs1436758212 134 dbSNP
rs1184789583 135 dbSNP
rs952975270 143 dbSNP
rs1373856169 146 dbSNP
rs1472911038 148 dbSNP
rs370088217 155 dbSNP
rs41471149 156 dbSNP
rs1470852697 157 dbSNP
rs1338876227 158 dbSNP
rs1462534862 160 dbSNP
rs994767969 162 dbSNP
rs960255813 170 dbSNP
rs940769022 181 dbSNP
rs144971686 188 dbSNP
rs1049679405 194 dbSNP
rs751815540 201 dbSNP
rs567307852 202 dbSNP
rs764327393 207 dbSNP
rs1327466828 215 dbSNP
rs1225754707 220 dbSNP
rs45605533 221 dbSNP
rs1010767619 232 dbSNP
rs893751784 239 dbSNP
rs568220009 240 dbSNP
rs990495191 246 dbSNP
rs1252110486 250 dbSNP
rs939035257 255 dbSNP
rs935135822 259 dbSNP
rs1176608534 260 dbSNP
rs1189639407 260 dbSNP
rs1481256607 260 dbSNP
rs1378411095 261 dbSNP
rs927614009 273 dbSNP
rs1465770575 274 dbSNP
rs901018027 280 dbSNP
rs1277469134 281 dbSNP
rs977862191 283 dbSNP
rs966848797 287 dbSNP
rs1340832647 290 dbSNP
rs1307902023 296 dbSNP
rs1041158533 298 dbSNP
rs1349184091 298 dbSNP
rs942504488 298 dbSNP
rs910883156 307 dbSNP
rs569167704 309 dbSNP
rs745623572 310 dbSNP
rs1230658907 317 dbSNP
rs983818433 320 dbSNP
rs1342193106 322 dbSNP
rs45560934 327 dbSNP
rs989695576 333 dbSNP
rs918821021 336 dbSNP
rs953991548 353 dbSNP
rs1191533297 357 dbSNP
rs1355858600 358 dbSNP
rs1266453724 362 dbSNP
rs1431258020 369 dbSNP
rs1294965268 372 dbSNP
rs15577 380 dbSNP
rs1338966840 384 dbSNP
rs1333729034 390 dbSNP
rs1369235826 395 dbSNP
rs565854333 396 dbSNP
rs998049379 410 dbSNP
rs901890796 412 dbSNP
rs1035868498 415 dbSNP
rs1398682685 419 dbSNP
rs1297191658 426 dbSNP
rs1166670643 428 dbSNP
rs980589450 436 dbSNP
rs1294830317 442 dbSNP
rs1018883508 443 dbSNP
rs1465513194 447 dbSNP
rs1004994190 464 dbSNP
rs1419191378 464 dbSNP
rs1167632264 467 dbSNP
rs374302222 467 dbSNP
rs868222264 472 dbSNP
rs1206681800 478 dbSNP
rs45561935 485 dbSNP
rs1236582437 497 dbSNP
rs1450391259 499 dbSNP
rs1011555424 502 dbSNP
rs1425668673 506 dbSNP
rs891814866 512 dbSNP
rs1349825650 518 dbSNP
rs1049245498 522 dbSNP
rs1456708811 525 dbSNP
rs532211426 534 dbSNP
rs1247720959 537 dbSNP
rs999457043 539 dbSNP
rs1318161782 549 dbSNP
rs900963151 553 dbSNP
rs1311840638 556 dbSNP
rs1319928240 557 dbSNP
rs776092278 559 dbSNP
rs76739889 560 dbSNP
rs528160347 562 dbSNP
rs35413555 567 dbSNP
rs1055425984 568 dbSNP
rs1208302915 573 dbSNP
rs1246448830 581 dbSNP
rs770898737 582 dbSNP
rs1355322876 587 dbSNP
rs746832553 595 dbSNP
rs1283860194 600 dbSNP
rs927645304 603 dbSNP
rs1042046703 604 dbSNP
rs1443122648 617 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control ...

- Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ggGUGGU-CGACGAGG-------------GACCGGGu 5'
            ||||| |:||| |:             ||||||| 
Target 5' --CACCAGGUUGC-CUAAGGAGGGGUGAACUGGCCCa 3'
1 - 34
Article - Hafner M; Landthaler M; Burger L; Khorshid et al.
- Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions C8166
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3 ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
Experimental Support 3 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HCT116
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8 PAR-CLIP data was present in ERX177603. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_5 PAR-CLIP data was present in ERX177618. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_8 PAR-CLIP data was present in ERX177627. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_5 PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8 PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5 ...

- Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research.

Article - Krell J; Stebbing J; Carissimi C; Dabrowska et al.
- Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
CLIP-seq Support 1 for dataset GSM545212
Method / RBP PAR-CLIP / AGO1
Cell line / Condition HEK293 / Control
Location of target site ENST00000306442.4 | 3UTR | GUUGCCUAAGGAGGGGUGAACUGGCCCAGGUUGGAAAC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM545215
Method / RBP PAR-CLIP / AGO4
Cell line / Condition HEK293 / Control
Location of target site ENST00000306442.4 | 3UTR | CACCAGGUUGCCUAAGGAGGGGUGAACUGGCCCAGGUUGGAAACA
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM1462572
Method / RBP PAR-CLIP / AGO2
Cell line / Condition C8166 / C8166 NL4-3
Location of target site ENST00000306442.4 | 3UTR | AAGGAGGGGUGAACUGGCCCAGGUUGGAAACAGA
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
87 hsa-miR-4640-5p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT100106 ABT1 activator of basal transcription 1 2 8
MIRT248144 LMBR1L limb development membrane protein 1 like 2 2
MIRT327062 KLHL15 kelch like family member 15 2 2
MIRT347231 GATAD2A GATA zinc finger domain containing 2A 2 2
MIRT450221 CENPN centromere protein N 2 2
MIRT451264 NDUFA11 NADH:ubiquinone oxidoreductase subunit A11 2 2
MIRT452701 C1orf226 chromosome 1 open reading frame 226 2 2
MIRT453212 CERS1 ceramide synthase 1 2 2
MIRT454822 POLR2J3 RNA polymerase II subunit J3 2 2
MIRT454883 RAD50 RAD50 double strand break repair protein 2 2
MIRT455783 TAF8 TATA-box binding protein associated factor 8 2 2
MIRT455858 TMEM254 transmembrane protein 254 2 2
MIRT457615 UPK3BL uroplakin 3B like 1 2 2
MIRT457822 ITPRIP inositol 1,4,5-trisphosphate receptor interacting protein 2 4
MIRT458344 NOC2L NOC2 like nucleolar associated transcriptional repressor 2 2
MIRT458376 ITM2C integral membrane protein 2C 2 2
MIRT458928 SAMD4B sterile alpha motif domain containing 4B 2 2
MIRT459066 WFIKKN2 WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 2 2
MIRT460138 ASB16 ankyrin repeat and SOCS box containing 16 2 2
MIRT460818 FSTL4 follistatin like 4 2 2
MIRT461285 COX10 COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor 2 2
MIRT462738 EFNB1 ephrin B1 2 2
MIRT464556 UBTF upstream binding transcription factor, RNA polymerase I 2 2
MIRT477910 DUSP2 dual specificity phosphatase 2 2 2
MIRT479073 CNNM4 cyclin and CBS domain divalent metal cation transport mediator 4 2 4
MIRT479534 CDC5L cell division cycle 5 like 2 4
MIRT485628 EEPD1 endonuclease/exonuclease/phosphatase family domain containing 1 2 2
MIRT489896 PPIC peptidylprolyl isomerase C 2 4
MIRT490737 SRCIN1 SRC kinase signaling inhibitor 1 2 2
MIRT491201 MLLT1 MLLT1, super elongation complex subunit 2 4
MIRT492681 PHYHIP phytanoyl-CoA 2-hydroxylase interacting protein 2 2
MIRT494593 ATG7 autophagy related 7 2 2
MIRT495061 PADI3 peptidyl arginine deiminase 3 2 4
MIRT496623 TMEM67 transmembrane protein 67 2 2
MIRT497177 ZBTB40 zinc finger and BTB domain containing 40 2 2
MIRT498217 TLN2 talin 2 2 2
MIRT498306 BCL11B B-cell CLL/lymphoma 11B 2 2
MIRT499668 NPHP3 nephrocystin 3 2 2
MIRT508080 ANKRD52 ankyrin repeat domain 52 2 2
MIRT509707 ANKRD23 ankyrin repeat domain 23 2 2
MIRT509841 FOS Fos proto-oncogene, AP-1 transcription factor subunit 2 2
MIRT512814 ARRDC2 arrestin domain containing 2 2 2
MIRT513353 SLIT1 slit guidance ligand 1 2 2
MIRT514293 FXYD5 FXYD domain containing ion transport regulator 5 2 2
MIRT516598 FAM89A family with sequence similarity 89 member A 2 4
MIRT516616 DARS2 aspartyl-tRNA synthetase 2, mitochondrial 2 2
MIRT518348 CCL5 C-C motif chemokine ligand 5 2 2
MIRT520130 WSB1 WD repeat and SOCS box containing 1 2 2
MIRT522072 ORAI2 ORAI calcium release-activated calcium modulator 2 2 2
MIRT526461 OSBPL5 oxysterol binding protein like 5 2 2
MIRT528278 MBL2 mannose binding lectin 2 2 2
MIRT534844 RAB15 RAB15, member RAS oncogene family 2 4
MIRT542245 HSPA4L heat shock protein family A (Hsp70) member 4 like 2 2
MIRT543299 ZNF585B zinc finger protein 585B 2 2
MIRT552456 ZNF410 zinc finger protein 410 2 2
MIRT553641 TJAP1 tight junction associated protein 1 2 2
MIRT557103 HOXA3 homeobox A3 2 2
MIRT570782 FANCA Fanconi anemia complementation group A 2 2
MIRT630912 ZMAT2 zinc finger matrin-type 2 2 2
MIRT631034 ZNF878 zinc finger protein 878 2 2
MIRT639017 AAK1 AP2 associated kinase 1 2 2
MIRT648596 ZYG11B zyg-11 family member B, cell cycle regulator 2 2
MIRT648939 ATP5A1 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle 2 2
MIRT652834 TACO1 translational activator of cytochrome c oxidase I 2 2
MIRT659347 CSRP1 cysteine and glycine rich protein 1 2 2
MIRT664163 APOBEC3F apolipoprotein B mRNA editing enzyme catalytic subunit 3F 2 2
MIRT670511 ZSCAN22 zinc finger and SCAN domain containing 22 2 2
MIRT671246 TMEM41B transmembrane protein 41B 2 2
MIRT672120 ATP6V0A2 ATPase H+ transporting V0 subunit a2 2 2
MIRT672313 CD3D CD3d molecule 2 2
MIRT672543 BRMS1L breast cancer metastasis-suppressor 1 like 2 2
MIRT673036 SGPL1 sphingosine-1-phosphate lyase 1 2 2
MIRT673814 DARS aspartyl-tRNA synthetase 2 2
MIRT674858 GINM1 glycoprotein integral membrane 1 2 2
MIRT674970 SH3BP2 SH3 domain binding protein 2 2 2
MIRT675185 KIF1C kinesin family member 1C 2 2
MIRT675219 UGDH UDP-glucose 6-dehydrogenase 2 2
MIRT675558 MED16 mediator complex subunit 16 2 2
MIRT682566 EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 2 2
MIRT684640 PDE4C phosphodiesterase 4C 2 2
MIRT689722 ATXN2 ataxin 2 2 2
MIRT693594 SLC39A1 solute carrier family 39 member 1 2 2
MIRT704745 CDKN2B cyclin dependent kinase inhibitor 2B 2 2
MIRT712779 ZNF154 zinc finger protein 154 2 2
MIRT718118 OTOF otoferlin 2 2
MIRT720115 SAMD4A sterile alpha motif domain containing 4A 2 2
MIRT720275 EIF1AD eukaryotic translation initiation factor 1A domain containing 2 2
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-4640 Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-mir-4640 Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-mir-4640 Cisplatin 5460033 NSC119875 approved resistant cell line (BxPC3)
hsa-miR-4640-5p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-4640-5p Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-4640-5p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (AsPC-1)
hsa-miR-4640-5p Gefitinib 123631 NSC715055 approved resistant cell line (PC9)
hsa-miR-4640-5p Osimertinib 71496458 NSC779217 approved resistant cell line (HCC827)
hsa-miR-4640-5p Osimertinib 71496458 NSC779217 approved resistant cell line (PC9)
hsa-miR-4640-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-4640-5p Gefitinib 123631 NSC715055 approved resistant cell line (HCC827)
hsa-miR-4640-5p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-4640-5p Paclitaxel 36314 NSC125973 approved resistant cell line (A2780)
hsa-miR-4640-5p Docetaxel+Cisplatin+5-Fluorouracil resistant tissue (hypopharyngeal squamous cell carcinoma)

Error report submission